Madelyn Burkart

Also affiliated with Wake Forest Baptist Comprehensive Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.”.

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064

N/A

0DataRank · unranked

0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis

UNC Libraries(2020)10.17615/yv1b-6n44

N/A

0DataRank · unranked

0 citations

Mirjan M. van Timmeren, Aleeza J. Roth, Peter Heeringa, Susan L. Hogan, Caroline J. Poulton +15 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876

N/A

0DataRank · unranked

42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis

Hematological Oncology(2021)10.1002/hon.2902

N/A

0DataRank · unranked

13 citations

Walter Hanel, Yi Chen, Menggang Yu, David T. Yang, Ling Guo +17 more

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2022009225

N/A

0DataRank · unranked

11 citations

Jeffrey M. Switchenko, Veronika Bachanová, James N. Gerson, Stefan K. Barta, Max J. Gordon +30 more

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022008916

N/A

0DataRank · unranked

29 citations

Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, Irl Brian Greenwell +17 more

Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.1589

N/A

0DataRank · unranked

3 citations

Yating Wang, Ivy Abraham, Anand Patel, Sarah Monick, Garth H. Rauscher +15 more